» Articles » PMID: 36063243

Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine

Abstract

Long-acting injectable antiretroviral medications are new to HIV treatment. People with HIV may benefit from a treatment option that better aligns with their preferences, but could also face new challenges and barriers. Authors from the fields of HIV, substance use treatment, and mental health collaborated on this commentary on the issues surrounding equitable implementation and uptake of LAI ART by drawing lessons from all three fields. We employ a socio-ecological framework beginning at the policy level and moving through the community, organizational, interpersonal, and patient levels. We look at extant literature on the topic as well as draw from the direct experience of our clinician-authors.

Citing Articles

Psychiatrists' Experiences, Training Needs, and Preferences Regarding Prescription and Management of HIV Pre-exposure Prophylaxis (PrEP) Within Psychiatric Care.

Bunting S, Feinstein B, Vidyasagar N, Wilson A, Schneider J, Ehsan D Psychiatr Res Clin Pract. 2024; 6(4):151-163.

PMID: 39669536 PMC: 11633549. DOI: 10.1176/appi.prcp.20240069.


HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence.

Scott G, Worku D Health Sci Rep. 2024; 7(9):e70089.

PMID: 39319247 PMC: 11420300. DOI: 10.1002/hsr2.70089.


Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South.

Haser G, Balter L, Gurley S, Thomas M, Murphy T, Sumitani J AIDS Res Hum Retroviruses. 2024; 40(12):690-700.

PMID: 38959116 PMC: 11807906. DOI: 10.1089/AID.2024.0007.


Low Uptake of Long-Acting Injectables in the First 2.5 Years Following Approval Among a Cohort of People Living With HIV.

Manghani P, Monroe A, Castel A, Kumar P, Phunmongkol J, Denyer R Open Forum Infect Dis. 2024; 11(5):ofae087.

PMID: 38756764 PMC: 11097117. DOI: 10.1093/ofid/ofae087.


Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida.

Fisk-Hoffman R, Ranger S, Gracy A, Gracy H, Manavalan P, Widmeyer M AIDS Patient Care STDS. 2024; 38(6):275-285.

PMID: 38686517 PMC: 11301705. DOI: 10.1089/apc.2024.0067.